PRS24 The CROSS-Coverage Effect of Dupilumab in Treating Coexisting Type 2 Inflammatory Diseases on the Italian National Health Service Expenditure - Jommi, C.; Fanelli, F.; Pedone, M.P.; Cipriani, F.; Canonica, G.W. (Value in health, 2020)